Literature DB >> 30855999

Sacubitril/Valsartan to Reduce Secondary Mitral Regurgitation.

Wilfried Mullens1,2, Pieter Martens1,3.   

Abstract

Entities:  

Keywords:  Editorials; guideline; heart failure; heart ventricles; mitral valve insufficiency

Mesh：

Substances：

Year:  2019        PMID： 30855999     DOI： 10.1161/CIRCULATIONAHA.118.038135

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Echocardiographic assessment of functional mitral regurgitation: opening Pandora's box?

Authors:  Andreas Hagendorff; Torsten Doenst; Volkmar Falk
Journal:  ESC Heart Fail       Date:  2019-07-25

2.  The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.

Authors:  Andrew J S Coats; Stefan D Anker; Andreas Baumbach; Ottavio Alfieri; Ralph Stephan von Bardeleben; Johann Bauersachs; Jeroen J Bax; Serge Boveda; Jelena Čelutkienė; John G Cleland; Nikolaos Dagres; Thomas Deneke; Dimitrios Farmakis; Gerasimos Filippatos; Jörg Hausleiter; Gerhard Hindricks; Ewa A Jankowska; Mitja Lainscak; Christoph Leclercq; Lars H Lund; Theresa McDonagh; Mandeep R Mehra; Marco Metra; Nathan Mewton; Christian Mueller; Wilfried Mullens; Claudio Muneretto; Jean-Francois Obadia; Piotr Ponikowski; Fabien Praz; Volker Rudolph; Frank Ruschitzka; Alec Vahanian; Stephan Windecker; Jose Luis Zamorano; Thor Edvardsen; Hein Heidbuchel; Petar M Seferovic; Bernard Prendergast
Journal:  Eur Heart J       Date:  2021-03-18       Impact factor: 29.983

3.  Plausible Functional Diagnostics by Rational Echocardiography in the Assessment of Valvular Heart Disease - Role of Quantitative Echocardiography in the Assessment of Mitral Regurgitation.

Authors:  Andreas Hagendorff; Stephan Stöbe
Journal:  Front Cardiovasc Med       Date:  2022-03-31

4.  Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective Study.

Authors:  Mohammad Abumayyaleh; Jonathan Demmer; Carina Krack; Christina Pilsinger; Ibrahim El-Battrawy; Michael Behnes; Assem Aweimer; Andreas Mügge; Siegfried Lang; Ibrahim Akin
Journal:  Am J Cardiovasc Drugs       Date:  2022-03-30       Impact factor: 3.283
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.